Detalhe da pesquisa
1.
Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities.
Immunity
; 28(6): 847-58, 2008 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-18549802
2.
Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells.
J Immunol
; 191(5): 2514-2525, 2013 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23904160
3.
Sculpting MHC class II-restricted self and non-self peptidome by the class I Ag-processing machinery and its impact on Th-cell responses.
Eur J Immunol
; 43(5): 1162-72, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23386199
4.
Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ).
J Immunol
; 188(10): 5020-31, 2012 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22504645
5.
Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection.
J Virol
; 85(17): 9051-9, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21715499
6.
Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model.
Eur J Immunol
; 39(3): 717-22, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19224639
7.
OX40 drives protective vaccinia virus-specific CD8 T cells.
J Immunol
; 181(11): 7969-76, 2008 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19017988
8.
A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus.
Nat Biotechnol
; 24(7): 817-9, 2006 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-16767078
9.
Modulating potency: Physicochemical characteristics are a determining factor of TLR4-agonist nanosuspension activity.
J Pharm Sci
; 103(3): 879-89, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24464844
10.
TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses.
Vaccine
; 31(49): 5848-55, 2013 Dec 02.
Artigo
Inglês
| MEDLINE | ID: mdl-24120675
11.
Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cells.
Vaccine
; 30(28): 4216-24, 2012 Jun 13.
Artigo
Inglês
| MEDLINE | ID: mdl-22542815
12.
Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140.
PLoS One
; 7(7): e41144, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22829921
13.
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant.
PLoS One
; 6(1): e16333, 2011 Jan 26.
Artigo
Inglês
| MEDLINE | ID: mdl-21298114
14.
Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.
Future Microbiol
; 5(2): 221-39, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20143946
15.
Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens.
Vaccine
; 27 Suppl 6: G21-6, 2009 Dec 30.
Artigo
Inglês
| MEDLINE | ID: mdl-20006135
16.
Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.
J Immunol
; 180(11): 7193-202, 2008 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18490718
17.
Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses.
J Immunol
; 178(11): 6814-20, 2007 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17513729